LOURDES SELEM: Open Payments
NPI 1982809380 · MIAMI LAKES, FL. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,644 in 81 payments from 13 companies in 2025. Trend: 2023 $2,060 · 2024 $1,176 · 2025 $1,644
Food & beverage: $1,544Education: $100
| Company | Payments | Amount |
|---|---|---|
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | 11 | $245 |
| ABBVIE INC. | 14 | $235 |
| Teva Pharmaceuticals USA, Inc. | 10 | $230 |
| Otsuka America Pharmaceutical, Inc. | 14 | $203 |
| Lundbeck LLC | 7 | $171 |
| Vanda Pharmaceuticals Inc. | 10 | $164 |
| E.R. Squibb & Sons, L.L.C. | 4 | $105 |
| Axsome Therapeutics, Inc. | 3 | $89 |
| Neurocrine BioSciences, Inc. | 2 | $70 |
| Almatica Pharma LLC | 2 | $48 |
Products named: REXULTI, CAPLYTA, VRAYLAR, AUSTEDO XR, FANAPT, COBENFY, Auvelity, INGREZZA.
Industry payments across FL — which companies pay providers there.
